Drug Interaction Study With Famotidine, Atazanavir, and Atazanavir/Ritonavir/Tenofovir

Completed · Phase 1

Conditions studied: HIV Infections

In brief

The purpose of this clinical research study is to assess the pharmacokinetics of atazanavir, identifying one or more dosing regimens of atazanavir/ritonavir/tenofovir when dosed with famotidine results in atazanavir exposures similar to those when atazanavir/ritonavir/tenofovir 300/100/300 mg is dosed without famotidine in healthy subjects.

Key facts

Study ID

NCT00365339

Run by

Bristol-Myers Squibb

People needed

40

Starts

2006-04-01

Expected to finish

2006-06-01

Last updated by the study team

2011-04-08

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy male and female subjects between the ages 18 to 50 years old with a BMI 18 to 32 kg/m2

Where it is running

• Local Institution — Hamilton, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.